Sign inGet started

Bowen Matthew

Insider CIK 2115025 · GLUE Principal Accounting Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
GLUE Monte Rosa Therapeutics, I S Sale2026-10-052026-10-0613$10.56 $13725,891SEC↗
GLUE Monte Rosa Therapeutics, I A Award deriv2026-04-062026-04-0719,500— $019,500SEC↗
GLUE Monte Rosa Therapeutics, I A Award2026-04-062026-04-074,300— $025,904SEC↗